Poikilodermatous Mycosis Fungoides - Rare Entity, Different Treatment Modalities

Acta Dermatovenerol Croat. 2018 Apr;26(1):48-52.

Abstract

Poikilodermatous mycosis fungoides (PMF) is a rare clinical variant of early-stage MF with peculiar histological features. Poikiloderma occurs in many different clinical conditions, which makes a diagnostic procedure more complicated. PMF belongs to a group of MF variants with low risk of disease progression. We report a case of a 64-year-old woman, who presented with mottled skin aspect of erythema, poikilodermatous patches (hypopigmentation, hyperpigmentation, atrophy, and telangiectasia) on more than 80% of the body. Based on clinical, histopathological, and immunohistochemical findings, we established the diagnosis of PMF. Staging procedure determined stage IIA. As skin-directed therapy was the treatment of choice, the patient was successfully treated with psoralen-UVA (PUVA), nbUVB plus retinoid (Re-nbUVB), and PUVA plus retinoid (Re-PUVA), however, with rapid recurrence.

Publication types

  • Case Reports

MeSH terms

  • Biopsy, Needle
  • Combined Modality Therapy
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Mycosis Fungoides / diagnosis
  • Mycosis Fungoides / pathology*
  • Mycosis Fungoides / therapy*
  • Neoplasm Invasiveness / pathology
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy
  • Neoplasm Staging
  • PUVA Therapy / methods
  • Prognosis
  • Retinoids / therapeutic use
  • Retreatment
  • Risk Assessment
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / therapy*
  • Ultraviolet Therapy / methods

Substances

  • Retinoids